BHC9:00 AMBausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Marketsbauschhealth.com
BHC8:00 AMPr SILIQ ® (brodalumab injection) Now Reimbursed Under Alberta’s Public Drug Plan, Improving Access for Eligible Patients with Moderate to Severe Plaque Psoriasisbauschhealth.com
BHC9:01 AMBausch Health Announces Availability of Solta Medical's Fraxel FTX® in Australiabauschhealth.com
BHC7:00 PMBausch Health Announces Availability of Solta Medical’s Fraxel FTX ® in Australia (Australia Version)bauschhealth.com
BHC9:02 AMBausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winnersbauschhealth.com
BHC9:00 AMBausch Health Announces 2026 Gastrointestinal Health Scholars Program Winnersbauschhealth.com
BHC9:00 AMPr ELIDEL ® (pimecrolimus) cream Now Reimbursed Under Alberta’s Public Drug Plan for Eligible Patients with Mild to Moderate Atopic Dermatitisbauschhealth.com
BHC8:00 AMLe Québec est la première province à inscrire Pr OKEDI MD (suspension injectable à libération prolongée de rispéridone) sur la liste des médicaments remboursés par le régime public pour le traitement de la schizophréniebauschhealth.com
BHC8:00 AMQuébec is the first province to list Pr OKEDI MC (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophreniabauschhealth.com